Title 42, The Public Health and WelfareRelease 119-73not60

§285i–1 Clinical Research on Eye Care and Diabetes

Title 42 › Chapter 6A— PUBLIC HEALTH SERVICE › Subchapter III— NATIONAL RESEARCH INSTITUTES › Part C— Specific Provisions Respecting National Research Institutes › Subpart 9— national eye institute › § 285i–1

Last updated Apr 5, 2026|Official source

Summary

The Director of the Institute may give research grants to one or more Diabetes Eye Research Institutions. The grants support clinical and health programs with four goals: offer full eye care for people with diabetes, develop better patient care methods through research, help move new research into everyday medical practice, and expand knowledge about the eye and diabetes by supporting more studies. Grant money must be used for four main kinds of work: finding the biochemical, cellular, and genetic causes of diabetic eye disease and spotting early problems (and training ophthalmologists in modern molecular and cell biology methods); building new technologies like video-based diagnostic tools to improve care, study retinal function and its effect on diabetes, and assess risks and treatments; turning vision research into better patient care using clinical and lab resources; and studying how well treatments and education programs work, including regional evaluations. Grants may also pay for needed equipment.

Full Legal Text

Title 42, §285i–1

The Public Health and Welfare, Source: USLM XML via OLRC

(a)The Director of the Institute, in consultation with the advisory council for the Institute, may award research grants to one or more Diabetes Eye Research Institutions for the support of programs in clinical or health services aimed at—

(1)providing comprehensive eye care services for people with diabetes, including a full complement of preventive, diagnostic and treatment procedures;

(2)developing new and improved techniques of patient care through basic and clinical research;

(3)assisting in translation of the latest research advances into clinical practice; and

(4)expanding the knowledge of the eye and diabetes through further research.

(b)Amounts received under a grant awarded under this section shall be used for the following:

(1)Establishing the biochemical, cellular, and genetic mechanisms associated with diabetic eye disease and the earlier detection of pending eye abnormalities. The focus of work under this paragraph shall require that ophthalmologists have training in the most up-to-date molecular and cell biological methods.

(2)Establishing new frontiers in technology, such as video-based diagnostic and research resources, to—

(A)provide improved patient care;

(B)provide for the evaluation of retinal physiology and its affect on diabetes; and

(C)provide for the assessment of risks for the development and progression of diabetic eye disease and a more immediate evaluation of various therapies aimed at preventing diabetic eye disease.

(3)The translation of the results of vision research into the improved care of patients with diabetic eye disease. Such translation shall require the application of institutional resources that encompass patient care, clinical research and basic laboratory research.

(4)The conduct of research concerning the outcomes of eye care treatments and eye health education programs as they relate to patients with diabetic eye disease, including the evaluation of regional approaches to such research.

(c)The purposes for which a grant under subsection (a) may be expended include equipment for the research described in such subsection.

Reference

Citations & Metadata

Citation

42 U.S.C. § 285i–1

Title 42, The Public Health and Welfare

Last Updated

Apr 5, 2026

Release point: 119-73not60